| Short Descr | Int derangement knee NOS |
|
Code
|
Description
|
|---|---|
| M22.90 | Unspecified disorder of patella, unspecified knee |
| M22.91 | Unspecified disorder of patella, right knee |
| M22.92 | Unspecified disorder of patella, left knee |
| M23.90 | Unspecified internal derangement of unspecified knee |
| M23.91 | Unspecified internal derangement of right knee |
| M23.92 | Unspecified internal derangement of left knee |
| No matching codes found | |
|
Code
|
Description
|
|---|---|
| G0281 | Electrical stimulation, (unattended), to one or more areas, for chronic stage iii and stage iv pressure ulcers, arterial ulcers, diabetic ulcers, and venous stasis ulcers not demonstrating measurable signs of healing after 30 days of conventional care, as part of a therapy plan of care |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care |
| G0329 | Electromagnetic therapy, to one or more areas for chronic stage iii and stage iv pressure ulcers, arterial ulcers, diabetic ulcers and venous stasis ulcers not demonstrating measurable signs of healing after 30 days of conventional care as part of a therapy plan of care |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg |
| J0704 | Injection, betamethasone sodium phosphate, per 4 mg [deleted] |
| J0800 | Injection, corticotropin, up to 40 units [deleted] |
| J1020 | Injection, methylprednisolone acetate, 20 mg [deleted] |
| J1030 | Injection, methylprednisolone acetate, 40 mg [deleted] |
| J1040 | Injection, methylprednisolone acetate, 80 mg [deleted] |
| J1094 | Injection, dexamethasone acetate, 1 mg |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg |
| J1700 | Injection, hydrocortisone acetate, up to 25 mg |
| J1710 | Injection, hydrocortisone sodium phosphate, up to 50 mg |
| J1720 | Injection, hydrocortisone sodium succinate, up to 100 mg |
| J1725 | Injection, hydroxyprogesterone caproate, 1 mg [deleted] |
| J2320 | Injection, nandrolone decanoate, up to 50 mg |
| J2321 | Injection, nandrolone decanoate, up to 100 mg [deleted] |
| J2322 | Injection, nandrolone decanoate, up to 200 mg [deleted] |
| J2650 | Injection, prednisolone acetate, up to 1 ml |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg [deleted] |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg [deleted] |
| J3300 | Injection, triamcinolone acetonide, preservative free, 1 mg |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
| J3302 | Injection, triamcinolone diacetate, per 5 mg |
| J3303 | Injection, triamcinolone hexacetonide, per 5 mg |
| J7312 | Injection, dexamethasone, intravitreal implant, 0.1 mg |
| L1843 | Knee orthosis, single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, prefabricated item that has been trimmed, bent, molded, assembled, or otherwise customized to fit a specific patient by an individual with expertise |
| L1844 | Knee orthosis, single upright, thigh and calf, with adjustable flexion and extension joint (unicentric or polycentric), medial-lateral and rotation control, with or without varus/valgus adjustment, custom fabricated |
| No matching codes found | |